Back to search

Article

Attenuated <i>Mycobacterium tuberculosis</i> Vaccine Protection in a Low Dose Murine Challenge Model

2023-03-18

Abstract excerpt

Bacillus Calmette–Guérin (BCG) remains the only clinically approved tuberculosis (TB) vaccine despite limited efficacy. Preclinical studies of next generation TB vaccines have typically used a murine aerosol challenge model that employs a high supraphysiologic challenge dose. Here we show that the protective efficacy of a live attenuated Mycobacterium tuberculosis (Mtb) vaccine candidate ΔLprG markedly exceeds th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1566d891-b43b-567f-8a76-49c0678f03e2
DOI
10.1101/2023.03.17.533226
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Attenuated <i>Mycobacterium tuberculosis</i> Vaccine Protection in a Low Dose Murine Challenge ModelDOI 10.1101/2023.03.17.533226
Select a neighboring publication to make it the new centre.